Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 21, 2017; 23(43): 7727-7734
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7727
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7727
Figure 1 Changes in pediatric Crohn’s disease activity index before and after 9-12 mo of thalidomide treatment in 10 patients.
There was a decrease of the pediatric CD activity index (PCDAI) scores in 9 patients (P < 0.05), 6 of them achieved clinical remission (PCDAI < 10). PCDAI: Pediatric Crohn’s disease activity index.
- Citation: Wang L, Hong Y, Wu J, Leung YK, Huang Y. Efficacy of thalidomide therapy in pediatric Crohn’s disease with evidence of tuberculosis. World J Gastroenterol 2017; 23(43): 7727-7734
- URL: https://www.wjgnet.com/1007-9327/full/v23/i43/7727.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i43.7727